Literature DB >> 20544291

Quality of life for head and neck cancer patients treated by combined modality therapy: the therapeutic benefit of technological advances in radiotherapy.

Tai-Lin Huang1, Wen-Ling Tsai, Chih-Yen Chien, Tsair-Fwu Lee, Fu-Min Fang.   

Abstract

PURPOSE: To evaluate quality of life (QoL) in patients with head and neck squamous cell carcinoma (HNSCC) treated by combined modality therapy, with a focus on the therapeutic benefits of QoL that result from technological advances in radiotherapy (RT).
METHODS: A cross-sectional survey of QoL using the EORTC QLQ-C30 and QLQ-H&N35 questionnaires was performed for 307 HNSCC survivors. One hundred and thirty-five patients were treated by two-dimensional RT (2DRT), 90 by three-dimensional conformal RT (3DCRT), and 82 by intensity-modulated RT (IMRT). The effect size between groups was calculated using Cohen's D coefficient.
RESULTS: Those who had a higher annual family income or were treated by more advanced RT techniques had better QoL outcomes. Compared with 2DRT, the impact of 3DCRT was small (Cohen's D: 0.02-0.40) on all QoL scales. For IMRT, the impact was small on most scales and moderate (Cohen's D: 0.55-0.60) on opening mouth, dry mouth, and sticky saliva. Compared with 3DCRT, the impact of IMRT was small (Cohen's D: 0.03-0.29) on all scales.
CONCLUSION: Advances in RT provided a positive effect on QoL outcome, especially on swallowing-related QoL scales, for patients with HNSCC treated by combined modality therapy.

Entities:  

Mesh:

Year:  2010        PMID: 20544291     DOI: 10.1007/s11136-010-9688-3

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  24 in total

Review 1.  Radiotherapy for nasopharyngeal carcinoma--transition from two-dimensional to three-dimensional methods.

Authors:  Peter M L Teo; Brigette B Y Ma; Anthony T C Chan
Journal:  Radiother Oncol       Date:  2004-11       Impact factor: 6.280

2.  Socioeconomic inequalities in health. No easy solution.

Authors:  N E Adler; W T Boyce; M A Chesney; S Folkman; S L Syme
Journal:  JAMA       Date:  1993 Jun 23-30       Impact factor: 56.272

3.  Parotid gland-sparing 3-dimensional conformal radiotherapy results in less severe dry mouth in nasopharyngeal cancer patients: a dosimetric and clinical comparison with conventional radiotherapy.

Authors:  Yee-Min Jen; Rompin Shih; Yaoh-Shiang Lin; Wan-Fu Su; Chih-Hung Ku; Chiou-Shiung Chang; Pei-Wei Shueng; Jing-Min Hwang; Dai-Wei Liu; Hsing-Lung Chao; Hon-Yi Lin; Li-Ping Chang; Weng-Yoon Shum; Chun-Shu Lin
Journal:  Radiother Oncol       Date:  2005-05       Impact factor: 6.280

4.  Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: update of the Memorial Sloan-Kettering experience.

Authors:  Suzanne L Wolden; William C Chen; David G Pfister; Dennis H Kraus; Sean L Berry; Michael J Zelefsky
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-06-02       Impact factor: 7.038

5.  Quality of life in patients cured from a carcinoma of the head and neck by radiotherapy: the importance of the target volume.

Authors:  P U Huguenin; D Taussky; K Moe; A Meister; B Baumert; U M Lütolf; C Glanzmann
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-08-01       Impact factor: 7.038

6.  Quality of life in head and neck cancer patients: validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35.

Authors:  K Bjordal; E Hammerlid; M Ahlner-Elmqvist; A de Graeff; M Boysen; J F Evensen; A Biörklund; J R de Leeuw; P M Fayers; M Jannert; T Westin; S Kaasa
Journal:  J Clin Oncol       Date:  1999-03       Impact factor: 44.544

7.  Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy.

Authors:  Johannes A Langendijk; Patricia Doornaert; Irma M Verdonck-de Leeuw; Charles R Leemans; Neil K Aaronson; Ben J Slotman
Journal:  J Clin Oncol       Date:  2008-08-01       Impact factor: 44.544

8.  Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trial.

Authors:  L J Peters; H Goepfert; K K Ang; R M Byers; M H Maor; O Guillamondegui; W H Morrison; R S Weber; A S Garden; R A Frankenthaler
Journal:  Int J Radiat Oncol Biol Phys       Date:  1993-04-30       Impact factor: 7.038

9.  Health-related quality of life for nasopharyngeal carcinoma patients with cancer-free survival after treatment.

Authors:  Fu-Min Fang; Herng-Chia Chiu; Wen-Rei Kuo; Chong-Jong Wang; Stephen W Leung; Hui-Chun Chen; Li-Min Sun; Hsuan-Chih Hsu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-07-15       Impact factor: 7.038

10.  Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program.

Authors:  Marije R Vergeer; Patricia A H Doornaert; Derek H F Rietveld; C René Leemans; Ben J Slotman; Johannes A Langendijk
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-12-26       Impact factor: 7.038

View more
  9 in total

1.  Heterogeneity in head and neck IMRT target design and clinical practice.

Authors:  Theodore S Hong; Wolfgang A Tomé; Paul M Harari
Journal:  Radiother Oncol       Date:  2012-03-09       Impact factor: 6.280

Review 2.  Head and neck cancer pain: systematic review of prevalence and associated factors.

Authors:  Tatiana V Macfarlane; Tanja Wirth; Sriyani Ranasinghe; Kim W Ah-See; Nick Renny; David Hurman
Journal:  J Oral Maxillofac Res       Date:  2012-04-01

Review 3.  [Radiation-related caries: etiology and possible preventive strategies. What should the radiotherapist know?].

Authors:  R Schweyen; J Hey; W Fränzel; D Vordermark; G Hildebrandt; T Kuhnt
Journal:  Strahlenther Onkol       Date:  2011-12-23       Impact factor: 3.621

Review 4.  Squamous cell carcinoma of the head and neck in the elderly.

Authors:  Jasenka Gugić; Primož Strojan
Journal:  Rep Pract Oncol Radiother       Date:  2012-08-10

5.  Antibody and lectin target podoplanin to inhibit oral squamous carcinoma cell migration and viability by distinct mechanisms.

Authors:  Jhon A Ochoa-Alvarez; Harini Krishnan; John G Pastorino; Evan Nevel; David Kephart; Joseph J Lee; Edward P Retzbach; Yongquan Shen; Mahnaz Fatahzadeh; Soly Baredes; Evelyne Kalyoussef; Masaru Honma; Martin E Adelson; Mika K Kaneko; Yukinari Kato; Mary Ann Young; Lisa Deluca-Rapone; Alan J Shienbaum; Kingsley Yin; Lasse D Jensen; Gary S Goldberg
Journal:  Oncotarget       Date:  2015-04-20

6.  Prospective functional outcomes in sequential population based cohorts of stage III/ IV oropharyngeal carcinoma patients treated with 3D conformal vs. intensity modulated radiotherapy.

Authors:  Paul Kerr; Candace L Myers; James Butler; Mohamed Alessa; Pascal Lambert; Andrew L Cooke
Journal:  J Otolaryngol Head Neck Surg       Date:  2015-05-13

7.  The 'radiation vacation': Parents' experiences of travelling to have their children's brain tumours treated with proton beam therapy.

Authors:  Sam G Cockle; Jane Ogden
Journal:  Health Psychol Open       Date:  2016-05-17

8.  The patient-reported outcome measures in oropharyngeal, laryngeal and hypopharyngeal cancer patients treated with Volumetric Modulated Arc based simultaneous integrated boost radiotherapy.

Authors:  Thiraviyam Elumalai; Ashutosh Mukherji; N Vijayaprabhu; Kannan Periasamy; Amdedkar Yadala
Journal:  Tech Innov Patient Support Radiat Oncol       Date:  2021-03-06

9.  Normal tissue complication probability model parameter estimation for xerostomia in head and neck cancer patients based on scintigraphy and quality of life assessments.

Authors:  Tsair-Fwu Lee; Pei-Ju Chao; Hung-Yu Wang; Hsuan-Chih Hsu; PaoShu Chang; Wen-Cheng Chen
Journal:  BMC Cancer       Date:  2012-12-04       Impact factor: 4.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.